The Many Aspects of Endothelins in Ischemia-Reperfusion Injury: Emergence of a Key Mediator

References

• Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mitsui Y., Yazaki Y., Goto K., Masaki T. A novel potent constrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411–415
   PubMed Web of Science ®Google Scholar
• Rubanyi G. M., Polokoff MA. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol Rev. 1994; 46: 325–415
   PubMed Web of Science ®Google Scholar
• Battistini B., D'Orléans-Juste P., Sirois P. Endothelins in physiopathology; Circulating plasma levels and presence in other biological fluids. Lab Invest. 1993; 68: 600–628
   PubMed Web of Science ®Google Scholar
• Battistini B., Botting R., Warner TD. Endothelins: A knockout in London. Trends Pharmacol Sci. 1995; 16: 217–222
   PubMedGoogle Scholar
• Warner T. D., Elliott J. D., Ohlstein EH. California dreamin' bout endothelin: Emerging new therapeutics. Trends Pharmacol Sci. 1996; 17: 177–181
   PubMed Web of Science ®Google Scholar
• Douglas S. A. Clinical development of endothelin receptor antagonists. Trends Pharmacol Sci. 1997; 18: 408–412
   PubMed Web of Science ®Google Scholar
• Webb D. J., Monge J. C., Rabelink T. J., Yanagisawa M. Endothelin: New discoveries and rapid progress in the clinic. Trends Pharmacol Sci. 1998; 19: 5–8
   PubMed Web of Science ®Google Scholar
• Opgenorth T. J., Wu JR Wong, Shiosaki K. Endothelin-converting enzymes. FASEB J. 1992; 6: 2653–2659
   PubMed Web of Science ®Google Scholar
• Turner A. J., Murphy LJ. Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol. 1996; 51(2)91–102
   PubMedGoogle Scholar
• Schweizer A., Valdenaire O., Nelbock P., De uschle U., Dumas JB Edwards, Stumpf J. G., Loffler BM. Human ECEI: Three isoforms with disctinct subcellular localizations. Biochem J. 1997; 328: 871–877
   PubMed Web of Science ®Google Scholar
• De Lombaert S., Stamford L. B., Blanchard L., Tan J., Hoyer D., Diefenbacher C. G., Wei D., Wallace E. M., Moskal M. A., Savage P., Jeng AY. Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11. Biorg Med Chem. 1997; 7: 1059–1064
   Google Scholar
• Ahn K., Sisneros A. M., Herman S. B., Pan S. M., Hupe D., Lee C., Nikam S., Cheng X. M., Doherty A. M., Schroeder R. L., Haleen S. J., Kaw S., Emoto N., Yanagisawa M. Novel selective quinazoline inhibitors of endothelin converting enzyme-1. Biochem Biophys Res Commun. 1998; 243(1)184–190
   PubMed Web of Science ®Google Scholar
• Tonnessen T., Christensen G., Oie E., Holt E., Kjekshus H., Smiseth O. A., Sejersted O. M., Attramadal H. Increased cardiac expression of endothelin-1 mRNA in ischemic heart failure in rats. Cardiovasc Res. 1997; 33(3)601–610
   PubMedGoogle Scholar
• Velasco C. E., Jackson E. K., Morrow J. A., Vitola J. V., Inagami T., Forman MB. Intravenous adenosine suppresses cardiac release of endothelin after myocardial ischaemia and reperfusion. Cardiovasc Res. 1993; 27(1)121–128
   PubMedGoogle Scholar
• Tsuji S., Sawamura A., Watanabe H., Takihara K., Park S. E., Azuma J. Plasma endothelin levels during myocardial ischemia and reperfusion. Life Sci. 1991; 48(18)1745–1750
   PubMedGoogle Scholar
• Ray S. G., McMurray J. J., Morton J. J., Dargie H. J. Circulating endothelin in acute ischaemic syndromes. Br Heart J. 1992; 67(5)383–386
   PubMedGoogle Scholar
• Firth J. D., Ratcliffe PJ. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest. 1992; 90(3)1023–1031
   PubMedGoogle Scholar
• Wu Weiping, Kuang Peigen, Li Zhenzhou. Changes of endothelin-1 gene expression in rat brains during ischemia and ischemic reperfusion. Chinese Med Sci J 1996; 11(4)228–231
   PubMedGoogle Scholar
• Duverger D., Viossat I., Chapelat M., Chabrier P. E., Pirotzky E., Braquet P. Focal cerebral ischemia in the rat: Measurement of brain tissue endothelin. Circ Met Cerveau. 1992; 9(2)85–93
   Google Scholar
• Viossat I., Duverger D., Chapelat M., Pirotzky E., Chabrier P. E., Braquet P. Elevated tissue endothelin content during focal cerebral ischemia in the rat. J Cardiovasc Pharmacol. 1993; 22(58)S306–S309
   Google Scholar
• Willette R. N., Ohlstein E. H., Pullen M., Sauermelch C. F., Cohen A., Nambi P. Transient forebrain ischemia alters acutely endothelin receptor density and immunoreactivity in gerbil brain. Life Sci. 1993; 52(1)35–40
   PubMedGoogle Scholar
• Pluta R. M., Boock R. J., Afshar J. K., Clouse K., Bacic M., Ehrenreich H., Oldfield EH. Source and cause of endothelin-1 release into cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 1997; 87(2)287–293
   PubMedGoogle Scholar
• Lampl Y., Fleminger G., Gilad R., Galron R., Sarova-Pinhas I., Sokolovsky M. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke. Stroke. 1997; 28(10)1951–1955
   PubMedGoogle Scholar
• Spatz M., Stanimirovic D., Strasser A., McCarron R. M. Nitro-L-arginine augments the endothelin-1 content of cerebrospinal fluid induced by cerebral ischemia. Brain Res 1995; 684(1)99–102
   PubMedGoogle Scholar
• Bian L. G., Zhang T. X., Zhao W. G., Shen J. K., Yang GY. Increased endothelin-1 in the rabbit model of middle cerebral artery occlusion. Neurosci Lett. 1994; 174(1)47–50
   PubMedGoogle Scholar
• Takasu A., Yagi K. I., Okada Y. Role of endothelin-1 in the failure of cerebral circulation after complete global cerebral ischemia. Resuscitation. 1995; 30(1)69–73
   PubMedGoogle Scholar
• Ziv I., Fleminger G., Djaldetti R., Achiron A., Melamed E., Sokolovsky M. Increased plasma endothelin-1 in acute ischemic stroke. Stroke. 1992; 23(7)1014–1016
   PubMed Web of Science ®Google Scholar
• Nakamura S., Nishiyama R., Serizawa A., Yokoi Y., Suzuki S., Konno H., Baba S., Muro H. Hepatic release of endothelin-1 after warm ischemia: Reperfusion injury and its hemodynamic effect. Transplantation. 1995; 59(5)679–684
   PubMedGoogle Scholar
• Gulluoglu B. M., Aktan A. O., Yegen C., Kurtel H., Yalin R. Endothelin release in augmented with captopril in rat ischemia-reperfusion injury of the liver. Res Exp Med. 1996; 196(4)227–233
   PubMedGoogle Scholar
• Kawamura E., Yamanaka N., Okamoto E., Tomoda F., Furukawa K. Response of plasma and tissue endothelin-1 to liver ischemia and its implication in ischemia-reperfusion injury. Hepatology. 1995; 21(4)1138–1143
   PubMed Web of Science ®Google Scholar
• Urakami A., Todo S., Zhu Y., Zhang S., Jin M. B., Ishizaki N., Shimamura T., Totsuka E., Subbotin V., Lee R., Starzl TE. Attenuation of ischemic liver injury by monoclonal anti-endothelin antibody, AwETN40. J Am Coll Surg. 1997; 185(4)358–364
   PubMedGoogle Scholar
• Ota T., Hirai R., Urakami A., Soga H., Nawa S., Shimizu N. Endothelin-1 levels in portal venous blood in relation to hepatic tissue microcirculation disturbance and hepatic cell injury after ischemia/reperfusion. Surg Today 1997; 27(4)313–320
   PubMedGoogle Scholar
• Sakurai T., Yanagisawa M., Masaki T. Molecular characterization of endothelin receptors. Trends Pharmacol Sci. 1992; 13: 103–108
   PubMed Web of Science ®Google Scholar
• Karne S., Jayawickreme C. K., Lerner MR. Cloning and characterization of an endothelin-3 specific receptor(ETC receptor) from Xenopus laevis dermal melanophores. J Biol Chem. 1993; 268: 19126–19133
   PubMed Web of Science ®Google Scholar
• Kumar C., Mwangi V., Nuthulaganti P., Wu H. L., Pullen M., Brun K., Aiyar H., Morris R. A., Naughton R., Nambi P. Cloning and characterization of a novel endothelin receptor from Xenopus heart. J Biol Chem. 1994; 269: 13414–13420
   PubMed Web of Science ®Google Scholar
• Warner T. D., Battistini B., Doherty A. M., Corder R. Endothelin receptor antagonists: Actions and rationale for their development. Biochem Pharmacol. 1994; 48: 625–635
   PubMed Web of Science ®Google Scholar
• Liu J., Casley D. J., Nayler WG. Ischemia causes externalization of ET-1 binding sites in rat cardiac membranes. Biochem Biophys Res Commun. 1989; 164: 1220–1225
   PubMedGoogle Scholar
• Liu J., Chen R., Casley D. J., Nayler W. G. Ischemia and reperfusion increase125l-labeled ET-1 binding in rat cardiac membranes. Am J Physiol. 1990; 258: H829–H835
   PubMed Web of Science ®Google Scholar
• Liu J., Gu X. H., Casley D. J., Nayler W. G. Reoxygenation, but neither hypoxia nor intermittent ischemia, increases [125]ET-1 binding to rat cardiac membranes. J Cardiovasc Pharmacol. 1990; 15: 436–443
   PubMedGoogle Scholar
• Nayler W. G., Ou R. C., Gu X. H., Casley D. J. Effect of amlodipine pretreatment on ischaemia-reperfusion-induced increases in cardiac endothelin-1 binding site density. J Cardiovasc Pharmacol. 1992; 20(3)416–420
   PubMedGoogle Scholar
• Velasco C., Giaid A., Williamson I., Yanagisawa M. Myocardial ischemia and local ET-1 production. Eur Heart J. 1994; 15(S)118
   Google Scholar
• Watts J. A., Chapat S., Johnson D. E., Janis R. A. Effects of nisoldipine upon vasoconstrictor responses and binding of endothelin-1 in ischemic and reperfused rat hearts. J Cardiovasc Pharmacol. 1992; 19(6)929–936
   PubMedGoogle Scholar
• Fu L. X., Sun X. Y., Hedner T., Feng Q. P., Liang Q. M., Hoebeke J., Hjalmarson A. Decreased density of mesenteric arteries but not of myocardial endothelin receptors and function in rats with chronic ischemic heart failure. J Cardiovasc Pharmacol. 1993; 22(2)177–182
   PubMedGoogle Scholar
• Stewart D. J., Baffour R. Ischemia-reperfusion potentiates ET-induced constriction in the coronary resistance bed. Endothelium-Derived Contracting Factors. Karger, Basel 1990; 212
   Google Scholar
• Neubauer S., Zimmermann S., Hirsch A., Pulzer F., Tian R., Bauer W., Bauer B., Ertl G. Effects of endothelin-1 in the isolated heart in ischemia/reperfusion and hypoxia/reoxygenation injury. J Mol Cell Cardiol. 1991; 23(12)1397–1409
   PubMedGoogle Scholar
• Saito T., Fushimi E., Abe T., Kimura Y., Takahashi K., Kudo Y., Nakagomi A., Miura M. Augmented contractile response to endothelin and blunted endothelium-dependent relaxation in post-ischemic reperfused coronary arteries. Jpn Cir J. 1992; 56(7)657–670
   PubMedGoogle Scholar
• Kohzuki M., Onodera H., Yasujima M., Itoyama Y., Kanazawa M., Sato T., Abe K. Endothelin receptors in ischemic rat brain and Alzheimer brain. J Cardiovasc Pharmacol. 1995; 26(53)S329–S331
   Google Scholar
• Moreland S., McMullen D. M., De laney C. L., Lee V. G., Hunt JT. Venous smooth muscle contains vasoconstrictor ETB-like receptors. Biochem Biophys Res Commun. 1992; 184: 100–106
   PubMed Web of Science ®Google Scholar
• Seo B., Oemar B. S., Siebenmann R., von Segesser L., Luscher T. F. Both ETA and ETB receptors mediate contraction to endothelin-1 in human blood vessels. Circ. 1994; 89: 1203–1208
   PubMed Web of Science ®Google Scholar
• Warner T. D., Mitchell J. A., De Nucci G., Vane JR. Endothelin-1 and endothelin-3 release EDRF from isolated perfused arterial vessels of the rat and rabbit. J Cardiovasc Pharmacol. 1989; 13: S85–S88
   PubMed Web of Science ®Google Scholar
• Bacon C. R., Davenport AP. Endothelin receptors in human coronary artery and aorta. Br J Pharmacol. 1996; 117(5)986–992
   PubMedGoogle Scholar
• Balwierczak J. L. Two subtypes of the ET receptor(ETA and ETB) mediate vasoconstriction in the perfused rat heart. J Cardiovasc Pharmacol. 1993; 22(58)S248–S551
   Google Scholar
• Teerlink J. R., Breu V., Sprecher U., Clozel M., Clozel JP. Potent vasoconstriction mediated by ETB receptors in canine coronary arteries. Circ Res. 1994; 74: 105–114
   PubMed Web of Science ®Google Scholar
• Battistini B., Forget M. A., Laight D. Potential role for endothelins in systemic inflammatory response syndrome(SIRS) with particular relationship to cytokines. Shock. 1996; 5(3)167–183
   PubMedGoogle Scholar
• Lopez Farrè A., Gomez D. Garre, Bernabeu F., Lopez Novoa JM. A role for endothelin in the maintenance of post-ischaemic renal failure in the rat. J Physiol. 1991; 444: 513–522
   PubMedGoogle Scholar
• Hughes A. K., Stricklett P. K., Padilla E., Kohan D. E. Effect of reactive oxygen species on endothelin-1 production by human mesangial cells. Kidney Int. 1996; 49(1)181–189
   PubMedGoogle Scholar
• Vaage J., Valen G. Pathophysiology and mediators of ischemia-reperfusion injury with special reference to cardiac surgery. A review. Scand J Thorac Cardiovasc Surg Suppl. 1993; 41: 1–18
   PubMedGoogle Scholar
• Abu-Zidan F. M., Walther S., Lennquist S. Role of platelet-activating factor on cardiovascular dysfunction in postischemic shock in pigs. Eur Surg Res. 1997; 29(2)133–141
   PubMedGoogle Scholar
• Tamura Y., Imaoka S., Gemba M., Funae Y. Effects of ischemia-reperfusion on individual cytochrome P450 isoforms in the rat kidney. Life Sci. 1997; 60(2)143–149
   PubMedGoogle Scholar
• Yue T. L., Feuerstein GZ. Platelet-activating factor: A putative neuromodulator and mediator in the pathophysiology of brain injury. Crit Rev Neurobiol. 1994; 8(1–2)11–24
   PubMedGoogle Scholar
• Donckier J., Hanet C., Stoleru L., Van-Mechelen H., Galanti L., Hayashida W., Keyeux A., Ketelslegers J. M., Pouleur H. Effects of endothelin-1 at pathophysiologic concentrations on coronary perfusion and mechanical function of normal and postischemic myocardium. J Cardiovasc Pharmacol. 1994; 23(2)212–219
   PubMedGoogle Scholar
• Cesari M., Pavan E., Sacchetto A., Rossi G. P. ET-1: A scientist's curiosity, or a real player in ischemic heart disease?. Am Heart J. 1996; 132: 1236–1243
   PubMedGoogle Scholar
• Clozel J. P., Clozel M. Effects of endothelin on the coronary vascular bed in open-chest dogs. Circ Res. 1989; 65: 1193–1200
   PubMedGoogle Scholar
• Grover G. J., Sleph P. G., Fox M., Trippodo N. C. Role of endothelin-1 and big endothelin-1 in modulating coronary vascular tone, contractile function and severity of ischemia in rat hearts. J Pharmacol Exp Ther. 1992; 263(3)1074–1082
   PubMedGoogle Scholar
• Hirata K., Matsuda Y., Akita H., Yokoyama M., Fukuzaki H. Myocardial ischaemia induced by endothelin in the intact rabbit: Angiographic analysis. Cardiovasc Res. 1990; 24: 879–883
   PubMedGoogle Scholar
• Cocks T. M., Broughton A., Dib M., Sudhir K., Angus JA. ET is blood vessel selective: Studies on a variety of human and dog vessels in vitro and on regional blood flow in the conscious rabbit. Clin Exp Pharmacol Physiol. 1989; 16: 243–246
   PubMed Web of Science ®Google Scholar
• Ezra D., Goldstein R. E., Czaja J. F., Feuerstein G. Z. Lethal ischemia due to coronary endothelin in pigs. Am J Physiol. 1989; 257: H339–H343
   PubMed Web of Science ®Google Scholar
• Davenport A. P., Nunez D. J., Hall J. A., Kaumann A. J., Brown MJ. Autoradiographical localization of binding sites for porcine [125]endothelin-1 in humans, pigs, and rats: Functional relevance in humans. J Cardiovasc Pharmacol. 1989; 13(55)S166–S170
   Google Scholar
• Chester A. H., Dashwood M. R., Clarke J. G., Larkin S. W., Davies G. J., Tadjkarimi S., et al. Influence of ET on human coronary arteries and localization of its binding sites. Am J Cardiol. 1989; 63: 1395–1398
   PubMed Web of Science ®Google Scholar
• Larkin S. W., Clarke J. G., Keogh B. E., Araujo L., Rhodes C., Davies G. J., et al. Intracoronary ET induces myocardial ischemia by small vessel constriction in the dog. Am J Cardiol. 1989; 64: 956–958
   PubMedGoogle Scholar
• Vemulapalli S., Rivelli M., Chiu PJS, Del Prado M., He JA. Phosphoramidon abolishes the increases in endothelin-1 release induced by ischemia-hypoxia in isolated perfused guinea pig lungs. J Pharmacol Exp Ther. 1992; 262(3)1062–1069
   PubMedGoogle Scholar
• Tsuji S., Sawamura A., Watanabe H., Takihara K., Park S. E., Azuma J. Plasma endothelin levels during myocardial ischemia and reperfusion. Life Sci. 1991; 48: 1745–1749
   PubMed Web of Science ®Google Scholar
• Tonnessen T., Naess P. A., Kirkeboen K. A., Offstad J., Ilebekk A., Christensen G. Release of endothelin from the porcine heart after short term coronary artery occlusion. Cardiovasc Res. 1993; 27(8)1482–1485
   PubMedGoogle Scholar
• Watanabe T., Suzuki N., Shimamoto N., Fujino M., Imada A. ET in myocardial infarction. Nature 1990; 344: 114
   PubMed Web of Science ®Google Scholar
• Watanabe T., Suzuki N., Shimamoto N., Fujino M., Imada A. Contribution of endogenous endothelin to the extension of myocardial infarct size in rats. Circ Res. 1991; 69: 370–377
   PubMed Web of Science ®Google Scholar
• Grover G. J., Dzwonczyk S., Parham CS. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion. Cardiovasc Res. 1993; 27(9)1613–1618
   PubMedGoogle Scholar
• Han H., Neubauer S., Braeker B., Ertl G. Endothelin-1 contributes to ischemia/reperfusion injury in isolated rat heart: Attenuation of ischemic injury by the endothelin-1 antagonists BQ123 and BQ610. J Mol Cell Cardiol. 1995; 27(2)761–766
   PubMedGoogle Scholar
• Lee J. Y., Warner R. B., Adler A. L., Opgenorth T. J. Endothelin ETA receptor antagonist reduces myocardial infarction induced by coronary artery occlusion and reperfusion in the rat. Pharmacology 1994; 49(5)319–324
   PubMedGoogle Scholar
• Hagar J. M., Geda M. Endogenous ET increases myocardial infarct size. Circ. 1995; 92(58)1455
   Google Scholar
• Li X. S., Wang Q. D., Pernow J. Beneficial effects of the endothelin receptor antagonist bosentan on myocardial and endothelial injury following ischaemia/reperfusion in the rat. Eur J Pharmacol. 1995; 283(1–3)161–168
   PubMedGoogle Scholar
• Wang Q. D., Li X. S., Lundberg J. M., Pernow J. Protective effects of non-peptide endothelin receptor antagonist bosentan on myocardial ischaemic and reperfusion injury in the pig. Cardiovasc Res. 1995; 29(6)805–812
   PubMedGoogle Scholar
• Watanabe T., Awane Y., Ikeda S., Fujiwara S., Kubo K., Kikuchi T., Kusumoto K., Wakimasu M., Fujino M. Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044, and the inhibition of myocardial infarct size in rats. Br J Pharmacol. 1995; 114(5)949–954
   PubMedGoogle Scholar
• McMurdo L., Thiemermann C., Vane JR. The effects of the endothelin ET-A receptor antagonist, FR 139317, on infarct size in a rabbit model of acute myocardial ischaemia and reperfusion. Br J Pharmacol. 1994; 112(1)75–80
   PubMedGoogle Scholar
• Mertz T. E., McClanahan T. B., Flynn M. A., Juneau P., Reynolds E. E., Hallak H., Bradford L., Gallagher KP. Endothelin-A receptor antagonism by PD 156707 does not reduce infarct size after coronary artery occlusion/reperfusion in pigs. J Pharmacol Exp Ther 1996; 278(1)42–49
   PubMedGoogle Scholar
• Richard V., Kaeffer N., Hogie M., Tron C., Blanc T., Thuillez C. Role of endogenous endothelin in myocardial and coronary endothelial injury after ischaemia and reperfusion in rats: Studies with bosentan, a mixed ET-A-ET-B antagonist. Br J Pharmacol. 1994; 113(3)869–876
   PubMedGoogle Scholar
• Erikson J. M., Velasco CE. Endothelin-1 and myocardial preconditioning. Am Heart J. 1996; 132(1 part 1)84–90
   PubMedGoogle Scholar
• Velasco C., Yanagisawa M., Williamson J., Fernando Triana J. Cardioprotective action of ET-1 during ischemia. Circ. 1993; 88(2)1544
   Google Scholar
• Velasco C., Yanagisawa M. ETs protect the ischemic myocardium. J Am Coll Cardiol. 1994; S: 30A
   Google Scholar
• Peng C. F., Li Y. J., De Wang H., Xiong Y. The protective effects of ischemic and calcitonin gene-related peptide-induced preconditioning on myocardial injury by endothelin-1 in the isolated perfused rat heart. Life Sci. 1996; 59(18)1507–1514
   PubMedGoogle Scholar
• Dawson D. A., Masayasu H., Graham D. I., Macrae I. M. The neuroprotective efficacy of ebselen(a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci Lett. 1995; 185(1)65–69
   PubMed Web of Science ®Google Scholar
• Sagher O., Jin Y., Thai Q. A., Fergus A., Kassell N. F., Lee KS. Cerebral microvascular responses to endothelins: The role of ET-A receptors. Brain Res. 1994; 658(1–2)179–184
   PubMedGoogle Scholar
• Patel T. R., Galbraith S., Graham D. I., Hallak H., Doherty A. M., McCulloch J. Endothelin receptor antagonist increases cerebral perfusion and reduces ischaemic damage in feline focal cerebral ischaemia. J Cerebr Blood Flow Met. 1996; 16(5)950–958
   PubMedGoogle Scholar
• Touzani O., Galbraith S., Siegl P., McCulloch J. Endothelin-B receptors in cerebral resistance arterioles and their functional significance after focal cerebral ischemia in cats. J Cerebr Blood Flow Met. 1997; 17: 1157–1165
   PubMedGoogle Scholar
• Nikolov R., Rami A., Krieglstein J. Endothelin-1 exacerbates focal cerebral ischemia without exerting neurotoxic action in vitro. Eur J Pharmacol Environ Toxicol Pharmacol. 1993; 2(2)205–208
   Google Scholar
• Fuxe K., Kurosawa N., Cintra A., Hallstrom A., Goiny M., Rosen L., Agnati L. F., Ungerstedt U. Involvement of local ischemia in endothelin-1 induced lesions of the neostriatum of the anaesthetized rat. Exp Brain Res. 1992; 88(1)131–139
   PubMedGoogle Scholar
• Robinson M. J., Macrae I. M., Todd M., Reid J. L., McCulloch J. Reduction of local cerebral blood flow to pathological levels by endothelin-1 applied to the middle cerebral artery in the rat. Neurosci Lett. 1990; 118(20)269–272
   PubMedGoogle Scholar
• Macrae I. M., Robinson M. J., Graham D. I., Reid J. L., McCulloch J. Endothelin-1-induced reductions in cerebral blood flow: Dose dependency, time course, and neuropathological consequences. J Cereb Blood flow Met. 1993; 13(2)276–284
   PubMedGoogle Scholar
• Sharkey J., Ritchie I. M., Kelly PAT. Perivascular microapplication of endothelin-1: A new model of factor cerebral ischaemia in the rat. J Cereb Blood Now Met. 1993; 13(5)865–871
   PubMedGoogle Scholar
• Sharkey J., Butcher SP. Characterisation of an experimental model of stroke produced by intracerebral microinjection of endothelin-1 adjacent to the rat middle cerebral artery. J Neurosci Methods. 1995; 60(1–2)125–131
   PubMed Web of Science ®Google Scholar
• Gartshore G., Dawson D., Patterson J., Macrae I. M. Consequences of transient focal cerebral ischaemia for second messenger and neurotransmitter binding in the rat: Quantitative autoradiographic analysis of forskolin, dopamine D-1 receptor binding and cerebral blood flow changes. Eur J Neurosci. 1996; 8(3)486–493
   PubMedGoogle Scholar
• Gartshore G., Dawson D., Patterson J., Macrae I. M. Topographic profile of reperfusion into MCA territory following endothelin-1-induced transient focal cerebral ischaemia. Neurosci Lett. 1996; 202(3)209–213
   PubMedGoogle Scholar
• Sharkey J., Butcher S. P., Kelly JS. Endothelin-1 induced middle cerebral artery occlusion: Pathological consequences and neuroprotective effects of MK801. J Autonom Nerv Syst. 1994; 49: S177–S185
   Google Scholar
• Dawson D. A., Graham D. I., McCulloch J., Macrae I. M. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and N-methyl-D-aspartate receptor antagonists in models of transient and permanent focal cerebral ischaemia. Br J Pharmacol. 1994; 113(1)247–253
   PubMedGoogle Scholar
• Barone F. C., Globus MYT, Price W. J., White R. F., Storer B. L., Feuerstein G. Z., Busto R., Ohlstein EH. Endothelin levels increase in rat focal and global ischemia. J Cereb Blood Now Met. 1994; 14(2)337–342
   PubMedGoogle Scholar
• Giuffrida R., Malatino LS. Endothelin and transient cerebral ischemia: An immunohistochemical study in the Mongolian gerbil. Brain Dysfunction 1992; 5(3–4)192–199
   Google Scholar
• Gartshore G., Patterson J., Macrae IM. Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol. 1997; 147(2)353–360
   PubMedGoogle Scholar
• Feuerstein G., Gu J. L., Ohlstein E. H., Barone F. C., Yue TL. Peptidic endothelin-1 receptor antagonist, BQ-123, and neuroprotection. Peptides. 1994; 15(3)467–469
   PubMed Web of Science ®Google Scholar
• Spatz M., Yasuma Y., Strasser A., McCarron R. M. Cerebral postischemic hypoperfusion is mediated by ET-A receptors. Brain Res. 1996; 726(1–2)242–246
   PubMedGoogle Scholar
• Barone F. C., White R. F., Elliott J. D., Feuerstein G. Z., Ohlstein EH. The endothelin receptor antagonist SB 217242 reduces cerebral focal ischemic brain injury. J Cardiovasc Pharmacol. 1995; 26(S3)S404–S407
   Google Scholar
• Barone F. C., Willette R. N., Yue T. L., Feurestein G. Therapeutic effects of endothelin receptor antagonists in stroke. Neurol Res. 1995; 17(4)259–264
   PubMed Web of Science ®Google Scholar
• Tatlisumak T., Carano RAD, Takano K., Opgenorth T. J., Sotak C. H., Fisher M. A novel endothelin antagonist, A-127722, attenuates ischemic lesion size in rats with temporary middle cerebral artery occlusion: A diffusion and perfusion MRI study. Stroke. 1998; 29(4)850–857
   PubMedGoogle Scholar
• McAuley M. A., Breu V., Graham D. I., McCulloch J. The effects of bosentan on cerebral blood flow and histopathology following middle cerebral artery occlusion in the rat. Eur J Pharmacol. 1996; 307(2)171–181
   PubMedGoogle Scholar
• Patel T. R., McCulloch J. Failure of an endothelin antagonist to modify hypoperfusion after transient global ischaemia in the rat. J Cerebr Blood Flow Met. 1996; 16: 490–499
   PubMed Web of Science ®Google Scholar
• Patel T. R., Galbraith S. L., McAuley M. A., Doherty A. M., Graham D. I., McCulloch J. Therapeutic potential of endothelin receptor antagonists in experimental stroke. J Cardiovasc Pharmacol. 1995; 26(S3)S412–S415
   Google Scholar
• Patel T. R., Galbraith S., McAuley M. A., McCulloch J. Endothelin-mediated vascular tone following focal cerebral ischaemia in the cat. J Cerebr Blood Flow Met. 1996; 16(4)679–687
   PubMedGoogle Scholar
• Findlay J. M., Macdonald R. L., Weir BKA. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Cerebrovasc Brain Metab. 1991; 3(4)336–361
   PubMedGoogle Scholar
• Kwan A. L., Bavbek M., Jeng A. Y., Maniara W., Toyoda T., Lappe R. W., Kassell N. F., Lee KS. Prevention and reversal of cerebral vasospasm by an endothelin-converting enzyme inhibitor, CGS 26303, in an experimental model of subarachnoid hemorrhage. J Neurosurg. 1997; 87(2)281–286
   PubMedGoogle Scholar
• Roux S., Breu V., Giller T., Neidhart W., Ramuz H., Coassolo P., Clozel J. P., Clozel M. Ro 61–1790, a new hydroso-break luble endothelin antagonist: General pharmacology and effects on experimental cerebral vasospasm. J Pharmacol Exp Ther. 1997; 283(3)1110–1118
   PubMedGoogle Scholar
• Takabatake T., Ise T., Ohta K., Kobayashi K. I. Endothelin effects on renal function and tubuloglomerular feedback. Kidney Int. 1991; 39: S122–S124
   Google Scholar
• Shibouta Y., Suzuki N., Shino A., Matsumoto H., Teashita Z. I., Kondo K., et al. Pathophysiological role of endothelin in acute renal failure. Life Sci. 1990; 46: 1611–1618
   PubMed Web of Science ®Google Scholar
• Sandok E. K., Lerman A., Stingo A. J., Perrella M. A., Gloviczki P., Burnett JC, Jr. Endothelin, a model of acute ischemic renal dysfunction: Modulating action of atrial natriuretic factor. J Am Soc Nephrol. 1992; 3(2)196–202
   PubMedGoogle Scholar
• Kon V., Yoshioka T., Fogo A., Ichikawa I. Glomerular action of endothelin in vivo. J Clin Invest. 1989; 83: 1762–1767
   PubMed Web of Science ®Google Scholar
• Vemulapalli S., Chiu PJS, Chintala M., Bernardino V. Attenuation of ischemic acute renal failure by phosphoramidon in rats. Pharmacology. 1993; 47(3)188–193
   PubMedGoogle Scholar
• Halim A., Kanayama N., Maehara K., Takahashi M., Terao T. HELPP syndrome-like biochemical parameters obtained with endothelin-1 injections in rabbits. Gynecol Obstet Invest. 1993; 35(4)193–198
   PubMedGoogle Scholar
• Goto M., Takei Y., Kawano S., Nagano K., Tsuji S., Masuda E., Nishimura Y., Okumura S., Kashiwagi T., et al. Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 1994; 19(3)675–681
   PubMedGoogle Scholar
• Spiegel H. U., Uhlmann D., Scommotau S., Giersch B., Sulkowski U. Effect of the endothelin receptor antagonist bosentan on postischemic oxygen supply of the liver. J Invest Surg. 1996; 9(6)439–445
   PubMedGoogle Scholar
• Koeppel T. A., Kraus T., Thies J. C., Gebhardl M. M., Otto G., Post S. Effects of mixed ET-A and ET-B-receptor antagonist(Ro-47-0203) on hepatic microcirculation after warm ischemia. Digest Dis Sci. 1997; 42(6)1316–1321
   PubMedGoogle Scholar
• Kitayama Y., Yamanaka N., Kawamura E., Kuroda N., Okamoto E. Hepatoprotective effect of the endothelin receptor antagonist TAK-044 against ischemia-reperfusion injury in the canine liver. Hepatology 1997; 25(4)938–942
   PubMedGoogle Scholar
• Jin M. B., Zhu Y., Zhang S., Ishizaki N., Tanaka H., Subbotin V. M., Lee R. G., Starzl T. E., Todo S. Attenuation of ischemic liver injury by a non-selective endothelin receptor antagonist. Transplant Proc. 1997; 29(1–2)1335
   PubMedGoogle Scholar
• Peralta C., Closa D., Hotter G., Gelpi E., Prats N., Rosello-Catafau J. Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem Biophys Res Commun. 1996; 229(1)264–270
   PubMedGoogle Scholar
• Pannen B. H., Al-Adili F., Bauer M., Clemens M. G., Geiger KK. Role of endothelins and nitric oxide in hepatic reperfusion injury in the rat. Hepatology 1998; 27(3)755–764
   PubMed Web of Science ®Google Scholar
• Hvaal K., Oie E., Attramadal H., Halvorsen V., Svindland A., Nordsletten L., Skjeldal S. Endothelin-1 is upregulated during skeletal muscle ischemia and reperfusion. J Orthopaed Res. 1998; 16(1)128–135
   PubMedGoogle Scholar
• Chang H., Wu G. J., Wang S. M., Hung C. R. The role of endothelin-1 during ischemia-reperfusion injury. Formosan Med Assoc. 1992; 91(12)1182–1188
   PubMedGoogle Scholar
• Miura S., Kurose I., Fukumura D., Suematsu M., Sekizuka E., Tashiro H., Serizawa H., Asako H., Tsuchiya M. Ischemic bowel necrosis induced by endothelin-1: An experimental model in rats. Digestion. 1992; 48(3)163–172
   Google Scholar
• Yegen C., Aktan A. O., Buyukgebiz O., Haklar G., Yalcin A. S., Yalin R., Ercan S. Effect of verapamil and iloprost(ZK 36374) on endothelin release after mesenteric ischemia-reperfusion injury. Eur Surg Res. 1994; 26(2)69–75
   PubMedGoogle Scholar
• Michida T., Kawano S., Masuda E., Kobayashi I., Nishimura Y., Tsujii M., Hayashi N., Takei Y., Tsuji S., Nagano K., Fusamoto H., Kamada T. Role of endothelin 1 in hemorrhagic shock-induced gastric mucosal injury in rats. Gastroenterol Jpn. 1994; 6(4)988–993
   Google Scholar
• Ma J. C., Liu Y. Y., Liu H. B., Wei G. Z., Sheng S. L., Yue X. H., Tian N. Effect of endothelin 1 on cerebral microcirculation and antagonistic action of drugs in rats with hemorrhagic shock. Zhongguo Yaolixue Yu Dulixue Zazhi. 1994; 8(3)175–178
   Google Scholar
• Watschinger B., Vychytil A., Schuller M., Hartter E., Traindl O., Pohanka E., et al. The pathophysiologic role of ET in acute vascular rejection after renal transplantation. Transplantation. 1991; 52: 743–746
   PubMed Web of Science ®Google Scholar
• Yamakado M., Hirata Y., Matsuoka H., Sugimoto T. Pathophysiological role of ET in renal transplantation. J Cardiovasc Pharmacol. 1991; 17: S477–S479
   Google Scholar
• Aharinejad S., Nourani F., Egerbacher M., Larson E. K., Miksovsky A., Bock P., Firbas W., McCuskey R. S., Marks SC, Jr. Sphincters of canine hepatic sublobular veins respond to endothelin-1 and -3. Anat Embryol. 1997; 196(4)299–309
   PubMedGoogle Scholar
• Yamanaka N., Takaya Y., Oriyama T., Furukawa K., Tanaka T., Tanaka W., Ichikawa N., Yasui C., Ando T., Yamanaka J., Kuroda N., Ko M., Takada M., Imakita M., Kitayama Y., Okamoto E., Sasaki S., Nakagaki I., Hori S., Ito T. Hepatoprotective effect of a nonselective endothelin receptor antagonist(TAK-044) in the transplanted liver. J Surg Res. 1997; 70(2)156–160
   PubMedGoogle Scholar
• Zoja C., Furci L., Ghilardi F., Zilio P., Benigni A., Remuzzi G. Cyclosporin-induced endothelial cell injury. Lab Invest. 1986; 55: 455–462
   PubMed Web of Science ®Google Scholar
• Epstein A., Beall A., Wynn J., Mulloy L., Brophy CM. Cyclosporine, but not FK506, selectively induces renal and coronary artery smooth muscle contraction. Surgery 1998; 123(4)456–460
   PubMedGoogle Scholar
• Kon V., Sugiura M., Inagami T., Harvie B. R., Ichikawa I., Hoover RL. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int. 1990; 37(6)1487–1491
   PubMedGoogle Scholar
• Grieff M., Shoheib S. A., Loertscher R., Stewart D. J. Cyclosporine induces elevation in circulating ET-1 following transplantation. J Am Soc Nephrol. 1990; 1: A758
   Google Scholar
• Bunchman T. E., Brookshire CA. Cyclosporine-induced synthesis of endothelin by cultured human endothelial cells. J Clin Invest. 1991; 88: 310–314
   PubMed Web of Science ®Google Scholar
• Ohta K., Hirata Y., Imai T., Kanno K., Emori T., Shichiri M., et al. Cytokine-induced release of ET-1 from porcine renal epithelial cell line. Biochem Biophys Res Commun. 1990; 169: 578–584
   PubMed Web of Science ®Google Scholar
• Nambi P., Pullen M., Contino L. C., Brooks D. P. Upregulation of renal ET receptors in rats with CsA-induced nephrotoxicity. Eur J Pharmacol. 1990; 187: 113–116
   PubMed Web of Science ®Google Scholar
• Brooks D. P., Ohlstein E. H., Contino L. C., Storer B., Pullen M., Caltabiano M., Nambi P. Effect of nifedipine on CsA-induced nephrotoxicity, urinary ET excretion, and renal ET receptor number. Eur J Pharmacol. 1991; 194: 115–117
   PubMed Web of Science ®Google Scholar
• Nayler W. Endothelin: Isoforms, binding sites and possible implications in pathology. Trends Pharmacol Sci. 1990; 11: 196–99
   Google Scholar
• Perico N., Dadan J., Remuzzi G. ET mediates the renal vasoconstriction induced by cyclosporine in the rat. J Am Soc Nephrol. 1990; 1: 76–83
   PubMed Web of Science ®Google Scholar